Published in BJU Int on March 01, 2005
Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors. Neoplasia (2007) 0.81
Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress. Sci Rep (2016) 0.75
Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo. Int J Mol Sci (2013) 0.75
Intermittent androgen suppression for rising PSA level after radiotherapy. N Engl J Med (2012) 8.64
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A (2005) 3.86
Occupational sitting and health risks: a systematic review. Am J Prev Med (2010) 2.98
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol (2013) 2.59
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int (2013) 2.38
Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology. J Magn Reson Imaging (2006) 1.94
Types and epidemiology of tendinopathy. Clin Sports Med (2003) 1.92
Bacterial sepsis after prostate biopsy--a new perspective. Urology (2009) 1.91
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer. J Natl Cancer Inst (2005) 1.90
A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol (2012) 1.85
Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer (2006) 1.71
Are workplace interventions to reduce sitting effective? A systematic review. Prev Med (2010) 1.64
Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs (2002) 1.54
Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int (2007) 1.52
Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer. Oncol Nurs Forum (2003) 1.50
First report on the use of a thinner (125)I radioactive seed within 20-gauge needles for permanent radioactive seed prostate brachytherapy: evaluation of postimplant dosimetry and acute toxicity. Brachytherapy (2013) 1.41
Key points in technique: Split thickness skin grafting to bare skull as a single stage procedure. J Plast Reconstr Aesthet Surg (2008) 1.40
Early weightbearing and ankle mobilization after open repair of acute midsubstance tears of the achilles tendon. Am J Sports Med (2003) 1.31
Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed (2007) 1.31
Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate (2002) 1.28
The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. Cancer Res (2005) 1.28
Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci U S A (2010) 1.25
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys (2013) 1.25
Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol (2007) 1.25
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS One (2013) 1.16
Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence. BJU Int (2011) 1.15
Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys (2010) 1.14
Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nurs (2007) 1.12
Quality of life, morbidity, and mortality results of a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen relapse after radiation therapy for locally advanced prostate cancer. Clin Genitourin Cancer (2008) 1.12
Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr Drug Deliv (2007) 1.12
Skeletal muscle metastases: a three-part study of a not-so-rare entity. Skeletal Radiol (2011) 1.09
The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets. Med Dosim (2012) 1.05
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU Int (2007) 1.02
Rethinking glycaemic control in critical illness--from concept to clinical practice change. Crit Care Resusc (2006) 1.02
Intermittent androgen suppression for prostate cancer. Nat Rev Urol (2010) 1.01
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancer. Clin Cancer Res (2012) 1.01
Tendon is covered by a basement membrane epithelium that is required for cell retention and the prevention of adhesion formation. PLoS One (2011) 1.01
Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 1.00
Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: the Canadian experience. Urology (2002) 1.00
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours. BJU Int (2011) 0.99
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease. BJU Int (2012) 0.99
Mathematical modelling of prostate cancer growth and its application to hormone therapy. Philos Trans A Math Phys Eng Sci (2010) 0.99
Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int (2011) 0.98
Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. Acad Radiol (2010) 0.97
Grouping of visual objects by honeybees. J Exp Biol (2004) 0.96
Quality of life issues in men undergoing androgen deprivation therapy: a review. Asian J Androl (2012) 0.95
Device for sectioning prostatectomy specimens to facilitate comparison between histology and in vivo MRI. J Magn Reson Imaging (2010) 0.93
Pigmented-anaerobic bacteria associated with canine periodontitis. Vet Microbiol (2005) 0.91
Rupture of the Achilles and patellar tendons. Clin Sports Med (2003) 0.91
A benchmark data set for model-based glycemic control in critical care. J Diabetes Sci Technol (2008) 0.91
The role of resection of pulmonary metastases from prostate cancer: a case report and literature review. Can Urol Assoc J (2011) 0.88
Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy. Magn Reson Imaging (2010) 0.86
Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective. BJU Int (2007) 0.86
Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial. Am J Surg Pathol (2002) 0.86
Transfer of Bacteroides splanchnicus to Odoribacter gen. nov. as Odoribacter splanchnicus comb. nov., and description of Odoribacter denticanis sp. nov., isolated from the crevicular spaces of canine periodontitis patients. Int J Syst Evol Microbiol (2008) 0.84
Multiparametric MRI maps for detection and grading of dominant prostate tumors. J Magn Reson Imaging (2012) 0.84
How 'male health' fits into the field of urology. Nat Rev Urol (2013) 0.82
Overview of glycemic control in critical care: relating performance and clinical results. J Diabetes Sci Technol (2007) 0.82
Registration of whole-mount histology and volumetric imaging of the prostate using particle filtering. IEEE Trans Med Imaging (2014) 0.82
Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences. Magn Reson Imaging (2007) 0.82
Denervation affects regenerative responses in MRL/MpJ and repair in C57BL/6 ear wounds. J Anat (2011) 0.81
Helical chirality in donor-acceptor catenanes. Org Lett (2004) 0.80
A case of type A aortic dissection with underlying fibromuscular dysplasia. J Radiol Case Rep (2011) 0.80
Implementation of a PDA based program to quantify urology resident in-training experience. Can J Urol (2003) 0.79
Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada. Sex Transm Dis (2015) 0.79
Evaluation of a monovalent companion animal periodontal disease vaccine in an experimental mouse periodontitis model. Vaccine (2005) 0.79
Intermittent androgen suppression in prostate cancer: an update of the Vancouver experience. Can J Urol (2003) 0.79
Prostate cancer in 2012: Paradigm shifts in prostate cancer diagnosis and treatment. Nat Rev Urol (2013) 0.78
Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells. J Pathol (2014) 0.78
Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series. Can Urol Assoc J (2011) 0.78
A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy. Am J Surg (2011) 0.77
N-acetyl-S-farnesyl-l-cysteine suppresses chemokine production by human dermal microvascular endothelial cells. Exp Dermatol (2012) 0.77
Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases. World J Surg Oncol (2013) 0.77
MR elastography and diffusion-weighted imaging of ex vivo prostate cancer: quantitative comparison to histopathology. NMR Biomed (2014) 0.77
Intermittent androgen suppression in prostate cancer: the Canadian experience. Urology (2002) 0.76
MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods. NMR Biomed (2014) 0.76
Development of a surgically optimized graft insertion suture technique to accommodate a tissue-engineered tendon in vivo. Biores Open Access (2013) 0.76
Intermittent androgen suppression--ready for prime time? J Urol (2012) 0.75
A Toddler with Bilateral Fractures of the Fibula. Radiol Case Rep (2016) 0.75
Evaluation of cartilage degeneration in a rat model of rotator cuff tear arthropathy. J Shoulder Elbow Surg (2013) 0.75
Trends in Syphilis Partner Notification Among Gay, Bisexual, and Other Men who Have Sex With Men in British Columbia, 2010 to 2013. Sex Transm Dis (2016) 0.75
Descending the reconstructive ladder with tube pedicles. J Plast Reconstr Aesthet Surg (2010) 0.75
Model-based registration of ex vivo and in vivo MRI of the prostate using elastography*. IEEE Trans Med Imaging (2013) 0.75
Increasing HIV treatment optimism but no changes in HIV risk behaviour among men who have sex with men (MSM) in Vancouver, Canada. J Acquir Immune Defic Syndr (2017) 0.75
Answer to case of the month # 99 scimitar syndrome. Can Assoc Radiol J (2005) 0.75
Alternative surgical approach to repair of the ascending aorta. Ann Thorac Surg (2011) 0.75
Registration of 3D ultrasound through an air-tissue boundary. IEEE Trans Med Imaging (2012) 0.75
Fusion of ultrasound B-mode and vibro-elastography images for automatic 3D segmentation of the prostate. IEEE Trans Med Imaging (2012) 0.75
Heterosexual couples and prostate cancer support groups: a gender relations analysis. Support Care Cancer (2014) 0.75
Mediator, TATA-binding protein, and RNA polymerase II contribute to low histone occupancy at active gene promoters in yeast. J Biol Chem (2016) 0.75
An unusual keratotic papular eruption. Arch Dermatol (2008) 0.75
A survey of urological manpower, technology, and resources in Canada. Can J Urol (2004) 0.75
Erratum to: heterosexual couples and prostate cancer support groups: a gender relations analysis. Support Care Cancer (2015) 0.75